STAT3 and periodontitis: These in vivo results suggest that TEPP-46’s therapeutic effect on periodontitis comes from inhibiting PKM2 nuclear translocation, thereby reducing STAT3 phosphorylation and subsequently reducing osteoclastogenesis.